… SARS-CoV 3CL pro inhibitors by virtual screening and 3D-QSAR studies. Virtual (in silico)
screening … The present study aimed to design novel non-peptide inhibitors against SARS-CoV …

… The coronavirus disease-2019 caused by a novel SARS CoV-… target for drug discovery
against SARS CoV-2. Twenty-one … virtual screening studies including coronavirus screening …

… are promising drug candidates for SARS-CoV-2, as they are … virtual screening method
to obtain promising inhibitors for these viral proteins that could be further utilized for SARS-CoV…

… We further used a virtual screening technique to shortlist the potent phytochemicals with
inhibiting the activity of SARS-CoV-2 M pro . Top hit molecules derived from these were then …

… coronavirus replication in preparation for future outbreaks. We explored two virtual screening
strategies to find inhibitors of the SARS-CoV… to screen a diverse library of 235 million virtual …

… -SARS-CoV-2 drug. At this juncture, we hope that our contribution towards drug repurposing
against target SARS-CoV-2 … against target SARS-CoV-2 proteins using bioinformatics tools. …

… severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) … -scale virtual screening for
small molecules that are potential CoV-2 … With ChemAI, we screened and ranked one billion …

… Materials & methods: Our virtual screening pipeline relies on the known 3D properties of
noncovalent ligands and features of crystalized complexes, applying consensus analyses in …

… drugs which target essential proteins of SARS-CoV-2, such as … Our present research focused
on virtual screening of a … were screened against the promising targets, namely SARS-CoV…

… Here we report a virtual screening approach with … and its use in identifying drugs targeting
SARS-CoV-2 main protease (M … FEP-ABFE−based virtual screening of the existing drug library …